Tianhong Shengjie, a Chinese company specializing in peripheral vascular intervention, has secured tens of millions of RMB in a recent funding round. The capital will be used to broaden its product offerings and advance into the fields of arterial and oncological embolization devices. AI
Summary written by gemini-2.5-flash-lite from 1 source. How we write summaries →
RANK_REASON This is a significant funding round for a company in the medical device sector. [lever_c_demoted from significant: ic=1 ai=0.0]
